Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP

← catalyst calendar

NCT03043716

Sponsored by ResMed (industry) · RMD — their whole pipeline →. With RWTH Aachen University.

Phase
Status
Completed
Study type
Observational
Enrollment
14,147actual
Sites
6
Country
Germany

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2017-08-01actualWhen the study began enrolling
Primary completion2026-07-31actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2026-07-31actualThe whole study's end, after follow-up
First posted2017-02-06estimatedWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-08-17actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Obstructive Sleep Apnea
  • Central Sleep Apnea
  • Mixed Sleep Apnea

Intervention

  • Other: PAP therapy with telemonitoring

Primary outcome

what the primary-completion date above is the date OF
Usage Patterns of PAP therapy with telemonitoring, assessed by data continuously recorded by the device and transferred via telemonitoring
measured 24 months

Permalink · RMD's whole pipeline · Catalyst calendar · Every registered study · What changed